Condition: Inflammatory Bowel Disease (IBD) · Ulcerative Colitis (UC) · Crohn's Disease · Sponsor: Mirador Therapeutics, Inc.
This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.
This description comes directly from the study's public registry record.
ASCEND-IBD Trial Center · 844-206-4980 · clinicaltrials@miradortx.com
Always discuss trial participation with your own doctor first.
| Mirador Therapeutics Selected Site | Birmingham, Alabama, United States | Recruiting |
| Mirador Therapeutics Selected Site | Scottsdale, Arizona, United States | Recruiting |
| Mirador Therapeutics Selected Site | Sun City, Arizona, United States | Recruiting |
| Mirador Therapeutics Selected Site | Little Rock, Arkansas, United States | Recruiting |
| Mirador Therapeutics Selected Site | Little Rock, Arkansas, United States | Recruiting |
| Mirador Therapeutics Selected Site | Colorado Springs, Colorado, United States | Recruiting |
| Mirador Therapeutics Selected Site | Littleton, Colorado, United States | Recruiting |
| Mirador Therapeutics Selected Site | Miami, Florida, United States | Recruiting |
| Mirador Therapeutics Selected Site | Miami, Florida, United States | Recruiting |
| Mirador Therapeutics Selected Site | Miami, Florida, United States | Recruiting |
| Mirador Therapeutics Selected Site | Orlando, Florida, United States | Recruiting |
| Mirador Therapeutics Selected Site | Palmetto Bay, Florida, United States | Recruiting |
+ 54 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07113522